RET polymorphisms and sporadic medullary thyroid carcinoma in a Portuguese population

被引:22
作者
Costa, P
Domingues, R
Sobrinho, LG
Bugalho, MJ [1 ]
机构
[1] Ctr Reg Oncol Lisboa, Serv Endocrinol, Inst Portugues Oncol Francisco Gentil, P-1099023 Lisbon, Portugal
[2] Ctr Reg Oncol Lisboa, Ctr Invest Patobiol Mol, P-1099023 Lisbon, Portugal
关键词
cancer susceptibility; MTC; polymorphisms; RET; meta-analysis;
D O I
10.1385/ENDO:27:3:239
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The genetic basis of the sporadic form of medullary thyroid carcinoma, derived from "C" cells, is still poorly understood. Somatic mutations of RET proto-oncogene have been reported at a variable frequency ranging from 23% to 69%. The hypothesis that low penetrance factors, such as polymorphisms, might contribute to the phenotype of this neoplasm has been addressed in a few studies conducting to conflicting results. Herein, we studied 100 individuals (50 patients and 50 controls) aiming to compare the frequencies of G691S, L769L, S836S, and S904S RET polymorphisms observed in patients with respect to controls. Furthermore, meta-analysis of published studies including the present results was conducted. To test the contributory role of the above polymorphisms for the development of "C"-cell hyperplasia, we studied a group of 10 individuals selected for having a positive pentagastrin test despite the absence of a RET germline mutation. An over-representation of the G691S polymorphism, particularly in females, was observed in patients with respect to controls, although not reaching the level of significance. Allelic frequencies of the other three polymorphisms were not different in patients and controls. Results obtained in the admittedly small group of individuals with a positive pentagastrin test are unlikely to support a major influence of any polymorphism in the development of "C"-cell hyperplasia. The meta-analysis provided evidence for a significant association of the S691 allele with MTC (odds ratio 1.54, 95% confidence interval 1.12-2.12, p = 0.008) and found no significant associations for the other polymorphisms.
引用
收藏
页码:239 / 243
页数:5
相关论文
共 41 条
[31]   The identification of false positive responses to the pentagastrin stimulation test in RET mutation negative members of MEN 2A families [J].
Marsh, DJ ;
McDowall, D ;
Hyland, VJ ;
Andrew, SD ;
Schnitzler, M ;
Gaskin, EL ;
Nevell, DF ;
Diamond, T ;
Delbridge, L ;
CliftonBligh, P ;
Robinson, BG .
CLINICAL ENDOCRINOLOGY, 1996, 44 (02) :213-220
[32]   GENETIC EVENTS IN TUMOR INITIATION AND PROGRESSION IN MULTIPLE ENDOCRINE NEOPLASIA TYPE-2 [J].
MULLIGAN, LM ;
GARDNER, E ;
SMITH, BA ;
MATHEW, CGP ;
PONDER, BAJ .
GENES CHROMOSOMES & CANCER, 1993, 6 (03) :166-177
[33]   DIVERSE PHENOTYPES ASSOCIATED WITH EXON-10 MUTATIONS OF THE RET PROTOONCOGENE [J].
MULLIGAN, LM ;
ENG, C ;
ATTIE, T ;
LYONNET, S ;
MARSH, DJ ;
HYLAND, VJ ;
ROBINSON, BG ;
FRILLING, A ;
VERELLENDUMOULIN, C ;
SAFAR, A ;
VENTER, DJ ;
MUNNICH, A ;
PONDER, BAJ .
HUMAN MOLECULAR GENETICS, 1994, 3 (12) :2163-2167
[34]   PROGNOSTIC FACTORS IN MEDULLARY-THYROID CARCINOMA - EVALUATION OF 741 PATIENTS FROM THE GERMAN-MEDULLARY-THYROID-CARCINOMA-REGISTER [J].
RAUE, F ;
KOTZERKE, J ;
REINWEIN, D ;
SCHRODER, S ;
ROHER, HD ;
DECKART, H ;
HOFER, R ;
RITTER, M ;
SEIF, F ;
BUHR, H ;
BEYER, J ;
SCHOBER, O ;
BECKER, W ;
NEUMANN, H ;
CALVI, J ;
WINTER, J ;
VOGT, H .
CLINICAL INVESTIGATOR, 1993, 71 (01) :7-12
[35]  
Robledo M, 2003, CANCER RES, V63, P1814
[36]   Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence [J].
Romei, C ;
Elisei, R ;
Pinchera, A ;
Ceccherini, I ;
Molinaro, E ;
Mancusi, F ;
Martino, E ;
Romeo, G ;
Pacini, F .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (04) :1619-1622
[37]   Germline sequence variant S836S in the RET proto-oncogene is associated with low level predisposition to sporadic medullary thyroid carcinoma in the Spanish population [J].
Ruiz, A ;
Antiñolo, G ;
Fernández, RM ;
Eng, C ;
Marcos, I ;
Borrego, S .
CLINICAL ENDOCRINOLOGY, 2001, 55 (03) :399-402
[38]   GLN-ARG192 POLYMORPHISM OF PARAOXONASE AND CORONARY HEART-DISEASE IN TYPE-2 DIABETES [J].
RUIZ, J ;
BLANCHE, H ;
JAMES, RW ;
GARIN, MCB ;
VAISSE, C ;
CHARPENTIER, G ;
COHEN, N ;
MORABIA, A ;
PASSA, P ;
FROGUEL, P .
LANCET, 1995, 346 (8979) :869-872
[39]   Incidence of RET mutations in patients with Hirschsprung's disease [J].
Sancandi, M ;
Ceccherini, I ;
Costa, M ;
Fava, M ;
Chen, B ;
Wu, Y ;
Hofstra, R ;
Laurie, T ;
Griffths, M ;
Burge, D ;
Tam, PKH .
JOURNAL OF PEDIATRIC SURGERY, 2000, 35 (01) :139-142
[40]   RET polymorphisms in codons 769 and 836 are not associated with predisposition to medullary thyroid carcinoma [J].
Wiench, M ;
Wloch, J ;
Wygoda, Z ;
Gubala, E ;
Oczko, M ;
Pawlaczek, A ;
Kula, D ;
Lange, D ;
Jarzab, B .
CANCER DETECTION AND PREVENTION, 2004, 28 (04) :231-236